Burn Clinical Trial - TXA Study in Major Burn Surgery

Status Terminated

Clinical Trial Summary

Major surgery can result in blood loss that can require a blood transfusion during and/or after surgery. Tranexamic acid (TXA) is a medication that was first introduced in the 1960's as a treatment for heavy menstrual bleeding. Over the past 20 years, it has been used and studied in patients undergoing open-heart surgery, liver transplantation, and urologic surgery. Investigators believe tranexamic acid may possibly decrease bleeding related to major burn surgery, resulting in reduced blood loss, lower blood transfusion rates, and possibly decreased hospital costs related to your stay. In this study, prior to each surgical procedure to treat the participants burn injury, the participant will receive either the drug tranexamic acid or placebo. The placebo is a liquid that looks like the tranexamic acid medicine, but does not have any active ingredient in it. In this study, both the tranexamic acid and the placebo are considered research.

Clinical Trial Description

Neither the participant nor the study doctor will choose what treatment the participant gets. The participant will have an equal chance of being given the tranexamic acid or the placebo. Neither the participant nor the study doctor will know which treatment the participant is receiving. The participant will receive one 1 gram dose of either tranexamic acid or placebo immediately before surgery. The dose of tranexamic acid or placebo will be given in the participants vein over a 10-minute period. Information from the participants medical record related to their surgery and recovery time in the hospital will be collected by medical staff assisting with this study and recorded on study forms. These study forms will be labeled with the participants study number instead of their name. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02753816
Study type	Interventional
Source	Spectrum Health Hospitals
Contact
Status	Terminated
Phase	N/A
Start date	April 2016
Completion date	December 3, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01302457` - Oral Care Study on Burn Patients	N/A
Completed	`NCT02729259` - H2O VR for Burns 2015	N/A
Completed	`NCT01965340` - Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission	N/A
Withdrawn	`NCT01225107` - Effect of Cranberry Extract on Infections in Burn Patients	N/A
Completed	`NCT01983280` - The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients	N/A
Completed	`NCT00591448` - Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients	N/A
Active, not recruiting	`NCT02083900` - Use of Banana Leaf Dressing on Donor Site Wounds	Phase 2
Completed	`NCT00242970` - Hypertrophic Scarring After Facial Burn	Phase 2
Completed	`NCT00585325` - Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes	N/A
Terminated	`NCT00591162` - Bone Disease in Severely Burned Children	Phase 2/Phase 3
Completed	`NCT03183622` - A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial	N/A
Terminated	`NCT02452255` - Fenofibrate and Propranolol in Burn Patients	Phase 2/Phase 3
Completed	`NCT02427659` - VR High Tech Pain Control Burn Wound Care	N/A
Not yet recruiting	`NCT00253279` - Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans	Phase 1
Completed	`NCT04516148` - A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting	Phase 4
Withdrawn	`NCT02029261` - Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury
Completed	`NCT00993889` - Virtual Reality Analgesia During Pediatric Physical Therapy	N/A
Terminated	`NCT01062191` - Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl	N/A
Completed	`NCT02394873` - A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound	Phase 1
Completed	`NCT00239668` - Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors